Associated Papers
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
40044654 (PubMed )
Supplement: 41397_2025_364_MOESM3_ESM.xlsx › Sheet1
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
Tate T et al.
Cancers, 2023
36831375 (PubMed )
Supplement: cancers-15-01031-s001.zip › Supplementary_Table_S1.xlsx › Table_S1
Mutational drivers of cancer cell migration and invasion.
Novikov NM et al.
British Journal of Cancer, 2021
A Global Map of G Protein Signaling Regulation by RGS Proteins.
Masuho I et al.
Cell, 2020
33007266 (PubMed )
Supplement: mmc5.xlsx › RGS7
Structural organization of a major neuronal G protein regulator, the RGS7-Gβ5-R7BP complex.
Patil DN et al.
Elife, 2018
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells.
Qutob N et al.
Scientific Reports, 2018
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
Krauthammer M et al.
Nature Genetics, 2012
22842228 (PubMed )
Supplement: NIHMS390374-supplement-1.pdf
Select a paper to view details